Evidence map›Paper›PMID 32922294›Full record

ArticleFrontiers in pharmacology2020

Targeting Cytokine Release Through the Differential Modulation of Nrf2 and NF-κB Pathways by Electrophilic/Non-Electrophilic Compounds.

Francesca Fagiani, Michele Catanzaro, Erica Buoso, Filippo Basagni, Daniele Di Marino, Stefano Raniolo, Marialaura Amadio, Eric H Frost, Emanuela Corsini, Marco Racchi and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Francesca FagianiDepartment of Drug Sciences, Pharmacology Section, University of Pavia, Pavia, Italy.
Michele CatanzaroDepartment of Drug Sciences, Pharmacology Section, University of Pavia, Pavia, Italy.
Erica BuosoDepartment of Drug Sciences, Pharmacology Section, University of Pavia, Pavia, Italy.
Filippo BasagniDepartment of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
Daniele Di MarinoDepartment of Life and Environmental Sciences, New York-Marche Structural Biology Center (NY-MaSBiC), Polytechnic University of Marche, Ancona, Italy.
Stefano RanioloUniversità della Svizzera Italiana (USI), Faculty of Biomedical Sciences, Institute of Computational Science-Center for Computational Medicine in Cardiology, CH-Lugano, Switzerland.
Marialaura AmadioDepartment of Drug Sciences, Pharmacology Section, University of Pavia, Pavia, Italy.
Eric H FrostDepartment of Microbiology and Infectiology, Centre de Recherches Cliniques, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, QC, Canada.
Emanuela CorsiniDepartment of Environmental Science and Policy, Università degli Studi di Milano, Milan, Italy.
Marco RacchiDepartment of Drug Sciences, Pharmacology Section, University of Pavia, Pavia, Italy.
Tamas FulopGeriatric Division, Department of Medicine, Faculty of Medicine and Health Sciences, Research Center on Aging, University of Sherbrooke, Sherbrooke, QC, Canada.
Stefano GovoniDepartment of Drug Sciences, Pharmacology Section, University of Pavia, Pavia, Italy.
Michela RosiniDepartment of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
Cristina LanniDepartment of Drug Sciences, Pharmacology Section, University of Pavia, Pavia, Italy.
University of Pavia · ITUniversité de Sherbrooke · CAUniversity of Bologna · ITMarche Polytechnic University · ITUniversità della Svizzera italiana · CHUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The transcription factor Nrf2 coordinates a multifaceted response to various forms of stress and to inflammatory processes, maintaining a homeostatic intracellular environment. Nrf2 anti-inflammatory activity has been related to the crosstalk with the transcription factor NF-κB, a pivotal mediator of inflammatory responses and of multiple aspects of innate and adaptative immune functions. However, the underlying molecular basis has not been completely clarified. By combining into new chemical entities, the hydroxycinnamoyl motif from curcumin and the allyl mercaptan moiety of garlic organosulfur compounds, we tested a set of molecules, carrying (pro)electrophilic features responsible for the activation of the Nrf2 pathway, as valuable pharmacologic tools to dissect the mechanistic connection between Nrf2 and NF-κB. We investigated whether the activation of the Nrf2 pathway by (pro)electrophilic compounds may interfere with the secretion of pro-inflammatory cytokines, during immune stimulation, in a human immortalized monocyte-like cell line (THP-1). The capability of compounds to affect the NF-κB pathway was also evaluated. We assessed the compounds-mediated regulation of cytokine and chemokine release by using Luminex X-MAP

Indexed as

antioxidantcurcumincytokine releaseinflammationMCP-1NF-κBNrf2TNFα

Identifiers

PMID32922294
PMCPMC7456937
OpenAlexW3049652624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.